Moreover, gut barrier disintegration, bacterial dissemination from the gut into lymphoid organs (mesenteric lymph nodes, spleen), and systemic Tnf levels in DSS-induced colitis was reduced by treatment with the HIF-1α inhibitor CG-598 [58]. This evidence concerns the gene HIF1A and colitis.